Level I | Good quality evidence |
Systematic review of RCTs with consistent findings High quality individual RCT |
Level II |
Limited quality patient orientated evidence |
Systematic review of lower quality studies or studies with inconsistent findings Low quality clinical trial Cohort studies Case-control studies |
Level III | Other |
Consensus guidelines, extrapolations from bench research, usual practice, opinion, disease-oriented evidence (intermediate or physiologic outcomes only), or case series |
[47] Calcium gluconate 10%, IV (calcium channel blocker toxicity): Proano L, Chiang WK, Wang RY. Calcium channel blocker overdose. Am J Emerg Med. 1995 Jul;13(4):444-50. http://www.ncbi.nlm.nih.gov/pubmed/7605536
Calcium gluconate 10%, IV (calcium channel blocker toxicity): Graudins A, Lee HM, Druda D. Calcium channel antagonist and beta-blocker overdose: antidotes and adjunct therapies. Br J Clin Pharmacol. 2016 Mar;81(3):453-61. https://www.ncbi.nlm.nih.gov/pubmed/26344579